Business Description
Maravai LifeSciences Holdings Inc
NAICS : 541714
SIC : 2834
ISIN : US56600D1072
Share Class Description:
FRA:MAR: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
MRVI.USAMAR.GermanyMRVI.Mexico IPO Date
2021-05-13Description
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.94 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.47 | |||||
| Debt-to-EBITDA | 0.86 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.3 | |||||
| Beneish M-Score | -6.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.4 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -75.4 | |||||
| 3-Year FCF Growth Rate | -52.8 | |||||
| 3-Year Book Growth Rate | 51 | |||||
| Future 3-5Y Total Revenue Growth Rate | 72.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.67 | |||||
| 9-Day RSI | 39.68 | |||||
| 14-Day RSI | 44.72 | |||||
| 6-1 Month Momentum % | 29.41 | |||||
| 12-1 Month Momentum % | -36.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8 | |||||
| Quick Ratio | 7.41 | |||||
| Cash Ratio | 6.57 | |||||
| Days Inventory | 120.69 | |||||
| Days Sales Outstanding | 86.95 | |||||
| Days Payable | 18.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | -6.5 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.52 | |||||
| Operating Margin % | -9.85 | |||||
| Net Margin % | -41.19 | |||||
| FCF Margin % | 21.22 | |||||
| ROE % | -23.59 | |||||
| ROA % | -5.61 | |||||
| ROIC % | 0.44 | |||||
| ROC (Joel Greenblatt) % | 290.53 | |||||
| ROCE % | 32.72 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.5 | |||||
| PB Ratio | 2.43 | |||||
| Price-to-Free-Cash-Flow | 16.64 | |||||
| Price-to-Operating-Cash-Flow | 8.01 | |||||
| EV-to-EBIT | 1.56 | |||||
| EV-to-Forward-EBIT | 62.56 | |||||
| EV-to-EBITDA | 1.45 | |||||
| EV-to-Forward-EBITDA | 16.56 | |||||
| EV-to-Revenue | 3.6 | |||||
| EV-to-Forward-Revenue | 3.81 | |||||
| EV-to-FCF | 17.32 | |||||
| Price-to-Peter-Lynch-Fair-Value | 10.07 | |||||
| Earnings Yield (Greenblatt) % | 63.99 | |||||
| FCF Yield % | 6.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Maravai LifeSciences Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 268.057 | ||
| EPS (TTM) (€) | -0.827 | ||
| Beta | 0 | ||
| Volatility % | 67.99 | ||
| 14-Day RSI | 44.72 | ||
| 14-Day ATR (€) | 0.293392 | ||
| 20-Day SMA (€) | 7.4425 | ||
| 12-1 Month Momentum % | -36.36 | ||
| 52-Week Range (€) | 4.2 - 13.9 | ||
| Shares Outstanding (Mil) | 132.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Maravai LifeSciences Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Maravai LifeSciences Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Maravai LifeSciences Holdings Inc Frequently Asked Questions
What is Maravai LifeSciences Holdings Inc(FRA:MAR)'s stock price today?
The current price of FRA:MAR is €6.95. The 52 week high of FRA:MAR is €13.90 and 52 week low is €4.20.
When is next earnings date of Maravai LifeSciences Holdings Inc(FRA:MAR)?
The next earnings date of Maravai LifeSciences Holdings Inc(FRA:MAR) is 2024-05-08.
Does Maravai LifeSciences Holdings Inc(FRA:MAR) pay dividends? If so, how much?
Maravai LifeSciences Holdings Inc(FRA:MAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers